Skip to content
← Back to this collection

PUBLICATIONS · 34297046

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2021 Jul 27
First author
Niemeyer CM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Niemeyer CM
      type
      Author
    2. name
      Flotho C
      type
      Author
    3. name
      Lipka DB
      type
      Author
    4. name
      Starý J
      type
      Author
    5. name
      Rössig C
      type
      Author
    6. name
      Baruchel A
      type
      Author
    7. name
      Klingebiel T
      type
      Author
    8. name
      Micalizzi C
      type
      Author
    9. name
      Michel G
      type
      Author
    10. name
      Nysom K
      type
      Author
    11. name
      Rives S
      type
      Author
    12. name
      Schmugge Liner M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Niemeyer CM
      type
      Author
    2. name
      Flotho C
      type
      Author
    3. name
      Lipka DB
      type
      Author
    4. name
      Starý J
      type
      Author
    5. name
      Rössig C
      type
      Author
    6. name
      Baruchel A
      type
      Author
    7. name
      Klingebiel T
      type
      Author
    8. name
      Micalizzi C
      type
      Author
    9. name
      Michel G
      type
      Author
    10. name
      Nysom K
      type
      Author
    11. name
      Rives S
      type
      Author
    12. name
      Schmugge Liner M
      type
      Author
    bibliography ids
    1. nci-bib-3308258d9b47c48191726629
    book metadata
    content sha256
    dcb24a08353f12f5b2ea2f3b0e8c3ad8de50188bafb33f10e9c21c6544dd2ae8
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2020004144
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34297046
    immutable id
    pubmed:34297046@dcb24a08353f12f5b2ea2f3b0e8c3ad8de50188bafb33f10e9c21c6544dd2ae8
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    14
    name
    Blood advances
    nlm unique id
    101698425
    pages
    2901-2908
    volume
    5
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34297046
      provenance
      batch id
      192b6392c165c6b06274
      provider
      NCBI PubMed ESummary
      record sha256
      d36ddab670d739f3acec34868e28474303ffc415ef2ee3e59e077ae648bdac72
      response sha256
      7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
      retrieved at
      2026-09-09T23:48:02.713075+00:00
      publication date
      display
      2021 Jul 27
      precision
      day
      year
      2021
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34297046/
      title
      Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.

      Preserved source evidence · Not medical advice